Silence Therapeutics plc (SLN)

NASDAQ: SLN · Real-Time Price · USD

14.72

-0.71 (-4.60%)

At close: Aug 11, 2026, 4:00 PM EDT

14.50

-0.22 (-1.49%)

Pre-market: Aug 12, 2026, 4:00 AM EDT

Silence Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	695	287	325	688	548	715
Market Cap Growth	192.06%	-11.61%	-52.78%	25.56%	-23.35%	17.04%
Enterprise Value	623.34	202.23	177.54	619.68	462.5	615.75
Last Close Price	14.72	6.08	6.88	17.37	15.25	23.89

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	1130.54	504.86	7.65	21.75	25.31	42.60
PB Ratio	18.08	-4.61	2.42	-31.29	20.52	62.03
P/TBV Ratio	-	-	2.56	-	29.53	575.74
P/FCF Ratio	-	-	-	-	-	96.24
P/OCF Ratio	-	-	-	-	-	77.70

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1013.56	355.52	4.18	19.58	21.36	36.68
EV/FCF Ratio	-	-	-	-	-	82.88

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.00	0	-0.01	0	0
Debt / FCF Ratio	-	-	-	-	-	0.03
Net Debt / Equity Ratio	1.87	1.36	-1.10	3.11	-3.20	-8.61
Net Debt / EBITDA Ratio	1.03	0.92	2.42	1.07	1.42	1.62
Net Debt / FCF Ratio	16059.56	1.22	2.16	1.38	1.50	-13.36
Asset Turnover	0.01	0.00	0.26	0.25	0.17	0.14
Quick Ratio	6.40	7.87	10.24	4.10	3.96	5.33
Current Ratio	7.42	8.72	11.11	4.62	4.41	5.69
Return on Equity (ROE)	54.03%	-251.26%	-78.88%	-2302.82%	-263.32%	-445.64%
Return on Assets (ROA)	-58.83%	-51.18%	-29.85%	-52.54%	-47.58%	-43.00%
Return on Invested Capital (ROIC)	-70.54%	-163.57%	-114.70%	-342.38%	-	-
Return on Capital Employed (ROCE)	-66.15%	-61.05%	-43.47%	-64.18%	-57.30%	-64.48%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
FCF Yield	-	-	-	-	-	1.04%
Buyback Yield / Dilution	-0.09%	-2.12%	-24.69%	-15.21%	-8.58%	-8.78%
Total Shareholder Return	-0.09%	-2.12%	-24.69%	-15.21%	-8.58%	-8.78%

SEC Filings: 10-K · 10-Q